Pulmonx Corp.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US7458481014
USD
2.14
0.39 (22.29%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
IRadimed Corp.
Organogenesis Holdings, Inc.
Outset Medical, Inc.
Mesa Laboratories, Inc.
Pulmonx Corp.
Surmodics, Inc.
Orthofix Medical, Inc.
Nano-X Imaging Ltd.
Castle Biosciences, Inc.
AirSculpt Technologies, Inc.
OraSure Technologies, Inc.
Why is Pulmonx Corp. ?
1
Flat results in Jun 25
  • ROCE(HY) Lowest at -66.88%
  • DEBT-EQUITY RATIO (HY) Highest at -40.03 %
  • OPERATING PROFIT(Q) Lowest at USD -14.41 MM
2
Risky - Negative EBITDA
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -74.28%, its profits have risen by 5.7%
3
High Institutional Holdings at 100%
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
4
Below par performance in long term as well as near term
  • Along with generating -74.28% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to Pulmonx Corp. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Pulmonx Corp. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Pulmonx Corp.
-67.62%
-0.76
98.56%
S&P 500
13.22%
0.61
20.17%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
23.33%
EBIT Growth (5y)
-174.48%
EBIT to Interest (avg)
-28.26
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.65
Sales to Capital Employed (avg)
0.54
Tax Ratio
0.79%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.64
EV to EBIT
-1.37
EV to EBITDA
-1.41
EV to Capital Employed
2.85
EV to Sales
0.88
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-207.42%
ROE (Latest)
-71.30%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Bearish
Bearish
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

9What is working for the Company
OPERATING CASH FLOW(Y)

Highest at USD -31.15 MM

NET PROFIT(HY)

Higher at USD -29.62 MM

INVENTORY TURNOVER RATIO(HY)

Highest at 1.48 times

NET SALES(Q)

Highest at USD 23.86 MM

-7What is not working for the Company
ROCE(HY)

Lowest at -66.88%

DEBT-EQUITY RATIO (HY)

Highest at -40.03 %

OPERATING PROFIT(Q)

Lowest at USD -14.41 MM

PRE-TAX PROFIT(Q)

Lowest at USD -15 MM

NET PROFIT(Q)

Lowest at USD -15.17 MM

Here's what is working for Pulmonx Corp.
Operating Cash Flow
Highest at USD -31.15 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Inventory Turnover Ratio
Highest at 1.48 times and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Net Sales
Highest at USD 23.86 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (USD MM)

Here's what is not working for Pulmonx Corp.
Debt-Equity Ratio
Highest at -40.03 % and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Operating Profit
Lowest at USD -14.41 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (USD MM)

Pre-Tax Profit
Lowest at USD -15 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (USD MM)

Net Profit
Lowest at USD -15.17 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is negative

Net Profit (USD MM)